Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications.

about

Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer Tackling dipeptidyl peptidase IV in neurological disorders.

P2860

Q36834005-E64C7AA0-98F9-4688-8286-6F19B78113DC Q49940117-4B4DD00B-46E5-434D-A6F6-93EA35D7EE90

P2860

Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications.

Item

http://www.wikidata.org/entity/Q35657065

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Emerging Role of PACAP as a Ne ...... Major Diabetes Complications.

@ast

Emerging Role of PACAP as a Ne ...... Major Diabetes Complications.

@en

type

Item

label

Emerging Role of PACAP as a Ne ...... Major Diabetes Complications.

@ast

Emerging Role of PACAP as a Ne ...... Major Diabetes Complications.

@en

prefLabel

Emerging Role of PACAP as a Ne ...... Major Diabetes Complications.

@ast

Emerging Role of PACAP as a Ne ...... Major Diabetes Complications.

@en

P1476

Emerging Role of PACAP as a Ne ...... n Major Diabetes Complications

@en

P2093

James A Waschek

http://www.w3.org/2001/XMLSchema#string

Rubina Marzagalli

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells

Pituitary adenylate cyclase-activating polypeptide ameliorates experimental acute ileitis and extra-intestinal sequelae

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Biochemistry and molecular cell biology of diabetic complications

VPAC receptors for VIP and PACAP

PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like cultures

PACAP and VIP affect NF1 expression in rat malignant peripheral nerve sheath tumor (MPNST) cells

Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation

Pituitary adenylate cyclase-activating polypeptide attenuates streptozotocin-induced apoptotic death of RIN-m5F cells through regulation of Bcl-2 family protein mRNA expression

P304

160928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/160928

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Filippo Drago

Alessandro Castorina

Soraya Scuderi

P577

2015-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276282878

http://www.w3.org/2001/XMLSchema#string

P698

26074958

http://www.w3.org/2001/XMLSchema#string

P932

4446501

http://www.w3.org/2001/XMLSchema#string

Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications.

about

P2860

P2860

Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932